Vasculometabolic and Inflammatory Effects of Aldosterone in Obesity
Author(s) -
Charlotte D.C.C. van der Heijden,
Rob ter Horst,
Inge van den Munckhof,
Kiki Schraa,
Jacqueline de Graaf,
Leo A. B. Joosten,
A.H. Jan Danser,
Mihai G. Netea,
Jaap Deinum,
Joost H.W. Rutten,
Niels P. Riksen
Publication year - 2020
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/clinem/dgaa356
Subject(s) - aldosterone , medicine , metabolic syndrome , endocrinology , renin–angiotensin system , inflammation , body mass index , aldosterone synthase , obesity , blood pressure
Not all obese individuals develop cardiovascular disease (CVD). Hyperaldosteronism is suggested to cause inflammation and metabolic dysregulation, and might contribute to CVD development in obese individuals.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom